Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (211-220 of 338) with videos related to

Pageof 34
Sort By:
American Heart Journal|October 1, 1984
Long-term renal hemodynamic effects of nadolol in patients with essential hypertensionE D Frohlich, F H Messerli, G R Deslinski, et al.
Journal of Steroid Biochemistry|August 1, 1976
Plasma deoxycorticosterone and aldosterone in essential hypertensionM Honda, W Nowaczynski, F H Messerli, et al.
Clinical Science (London, England : 1979)|December 1, 1979
Systemic haemodynamic effects of biofeedback in borderline hypertensionF H Messerli, J G Decarvalho, B Christie, et al.
Journal of the American Society of Nephrology : JASN|March 1, 1995
How should renal hemodynamic data be indexed in obesity?R E Schmieder, A H Beil, H Weihprecht, et al.
Archives of Internal Medicine|February 1, 1986
Renal involvement follows cardiac enlargement in essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
The American Journal of Medicine|July 1, 1979
Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume stateF H Messerli, J G DeCarvalho, B Christie, et al.
Journal of Human Hypertension|August 4, 2006
Hypertension and breast cancer: an association revisited?P K Y Goon, F H Messerli, G Y H Lip
Journal of Human Hypertension|May 1, 1997
Disparate effects of ACE-inhibitors and calcium antagonists on left ventricular structure and function in essential hypertensionF C Aepfelbacher, F H Messerli, E Nunez, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
The problem of obesity and hypertensionE D Frohlich, F H Messerli, E Reisin, et al.
Chest|December 1, 1987
Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesityC J Lavie, C Amodeo, H O Ventura, et al.
Pageof 34

Showing results (211-220 of 338) with videos related to

Sort By:
Pageof 34
American Heart Journal|October 1, 1984
Long-term renal hemodynamic effects of nadolol in patients with essential hypertensionE D Frohlich, F H Messerli, G R Deslinski, et al.
Journal of Steroid Biochemistry|August 1, 1976
Plasma deoxycorticosterone and aldosterone in essential hypertensionM Honda, W Nowaczynski, F H Messerli, et al.
Clinical Science (London, England : 1979)|December 1, 1979
Systemic haemodynamic effects of biofeedback in borderline hypertensionF H Messerli, J G Decarvalho, B Christie, et al.
Journal of the American Society of Nephrology : JASN|March 1, 1995
How should renal hemodynamic data be indexed in obesity?R E Schmieder, A H Beil, H Weihprecht, et al.
Archives of Internal Medicine|February 1, 1986
Renal involvement follows cardiac enlargement in essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
The American Journal of Medicine|July 1, 1979
Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume stateF H Messerli, J G DeCarvalho, B Christie, et al.
Journal of Human Hypertension|August 4, 2006
Hypertension and breast cancer: an association revisited?P K Y Goon, F H Messerli, G Y H Lip
Journal of Human Hypertension|May 1, 1997
Disparate effects of ACE-inhibitors and calcium antagonists on left ventricular structure and function in essential hypertensionF C Aepfelbacher, F H Messerli, E Nunez, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1983
The problem of obesity and hypertensionE D Frohlich, F H Messerli, E Reisin, et al.
Chest|December 1, 1987
Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesityC J Lavie, C Amodeo, H O Ventura, et al.
Pageof 34